DUOCUTAN
PolandThe leaflet does not provide specific indications for the use of the medicinal product; it only provides information regarding its composition and method of administration.
Frequently asked questions
How to use Duocutan?
The gel should be applied directly to the skin.
How should the medicine be stored?
The medicine must be stored in a refrigerator (at a temperature between 2°C and 8°C). Do not freeze. After the tube is opened for the first time, it should not be stored at a temperature above 25°C.
How long can the medicine be used after opening the package?
After the tube is opened for the first time, the medicine can be used for 2 months.
What precautions should be taken when using the gel?
The product may discolor hair as well as colored or dyed fabrics, furniture, and carpets.
Instructions for use
Table of contents
- 2. CONTENT OF ACTIVE SUBSTANCES
- 3. LIST OF EXCIPIENTS
- 4. PHARMACEUTICAL FORM AND PACKAGE CONTENTS
- 5. METHOD AND ROUTE OF ADMINISTRATION
- 6. WARNING ON STORAGE OF THE MEDICINAL PRODUCT
- 7. OTHER SPECIAL PRECAUTION, IF NECESSARY
- 8. EXPIRY DATE
- 9. SPECIAL STORAGE CONDITIONS
- 10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED
- 11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
- 12. MARKETING AUTHORISATION NUMBER
- 13. BATCH NUMBER
- 14. GENERAL AVAILABILITY CATEGORY
INFORMATION ON IMMEDIATE PACKAGING
Tube
1. NAME OF THE MEDICINAL PRODUCT
Duocutan, 10 mg/g + 30 mg/g, gel
Clindamycinum + Benzoylis peroxidum
2. CONTENT OF ACTIVE SUBSTANCES
1 g of gel contains 0.01 g (1% w/w) clindamycin as clindamycin phosphate and 0.03 g (3% w/w) benzoyl peroxide as benzoyl peroxide with water.
3. LIST OF EXCIPIENTS
Excipients: carbomer, dimethicone 100, disodium lauryl sulfosuccinate, disodium edetate,
glycerol 85% (E 422), colloidal anhydrous silica, poloxamer 182, purified water, sodium
hydroxide (E 524) (for pH adjustment).
4. PHARMACEUTICAL FORM AND PACKAGE CONTENTS
gel
30 g
60 g
5. METHOD AND ROUTE OF ADMINISTRATION
For topical application to the skin.
Read the entire leaflet before using the medicine.
6. WARNING ON STORAGE OF THE MEDICINAL PRODUCT
KEEP OUT OF SIGHT AND REACH OF CHILDREN
Keep the medicine in a place out of sight and reach of children.
7. OTHER SPECIAL PRECAUTION, IF NECESSARY
Warning: May bleach hair and coloured or dyed fabrics, furniture, and carpets.
8. EXPIRY DATE
EXP
9. SPECIAL STORAGE CONDITIONS
Store in a refrigerator (2°C-8°C). Do not freeze.
Shelf life after first opening of the tube: 2 months. After first opening of the tube, do not store at temperatures above 25°C.
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED
MEDICINAL PRODUCT OR WASTE DERIVING FROM SUCH MEDICINAL PRODUCT, IF
APPLICABLE
11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
{ Logo of the marketing authorisation holder }
12. MARKETING AUTHORISATION NUMBER
Authorisation number 28599
13. BATCH NUMBER
Lot
14. GENERAL AVAILABILITY CATEGORY
Rp – Prescription-only medicine.
15. INSTRUCTIONS FOR USE
16. INFORMATION IN BRAILLE
17. UNIQUE IDENTIFIER – 2D CODE
18. UNIQUE IDENTIFIER – HUMAN-READABLE DATA
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| ACNATAC | gel |
|
Viatris Healthcare Limited |
| ACNATAC | gel |
|
Viatris Healthcare Limited |
| ACNATAC | gel |
|
Viatris Healthcare, Lda. |
| ACNATAC | gel |
|
Viatris Healthcare Limited |
| BENZACNE DUO | gel |
|
Jadran-Galenski laboratorij d.d. Orifarm Generics A/S |
| DUAC | gel |
|
GlaxoSmithKline Trading Services Limited |
| DUAC | gel |
|
GlaxoSmithKline Monoprosopi A.E.B.E. |
| DUAC | gel |
|
GlaxoSmithKline Monoprosopi A.E.B.E. |
| DUOCUTAN | gel |
|
mibe GmbH Pharmaceuticals Sun-Farm Sp. z o.o. |
The original data is available in the language of the country of manufacture.
Data source: Register of Medicinal Products of Poland (URPL)
Data last verified: September 01, 2026